• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转移性梭形细胞癌:顺铂和5-氟尿嘧啶诱导的完全缓解

Metastatic spindle cell carcinoma: a complete response induced by cisplatin and 5-fluorouracil.

作者信息

Colozza M, Grignani F, Crino L, Tonato M, Davis S

机构信息

Istituto di Clinica Medica, Università di Perugia, Italy.

出版信息

Anticancer Res. 1988 May-Jun;8(3):457-8.

PMID:3389747
Abstract

A patient with biopsy-proven spindle cell carcinoma, of unknown primary site, metastatic to the neck and to the lung, was treated with chemotherapy consisting of cisplatin (20 mg/m2/day) on days 1-5 and 5-fluorouracil (1000 mg/m2/day) on days 1-5. The regimen was repeated every 28 days. The patient had a complete response confirmed by computerized tomography. The patient is in a disease-free status 12 months after diagnosis. Toxicity was mild. To our knowledge, this case represents the first chemotherapy induced complete response documented in this rare entity.

摘要

一名经活检证实为梭形细胞癌的患者,原发部位不明,已转移至颈部和肺部,接受了化疗,化疗方案为第1 - 5天使用顺铂(20 mg/m²/天),第1 - 5天使用5-氟尿嘧啶(1000 mg/m²/天)。该方案每28天重复一次。经计算机断层扫描确认患者获得完全缓解。患者在诊断后12个月处于无病状态。毒性反应轻微。据我们所知,该病例是这种罕见疾病中首例有记录的化疗诱导完全缓解病例。

相似文献

1
Metastatic spindle cell carcinoma: a complete response induced by cisplatin and 5-fluorouracil.转移性梭形细胞癌:顺铂和5-氟尿嘧啶诱导的完全缓解
Anticancer Res. 1988 May-Jun;8(3):457-8.
2
Cisplatin and 5-fluorouracil for metastatic squamous cell carcinoma from unknown primary.顺铂和5-氟尿嘧啶用于原发灶不明的转移性鳞状细胞癌
Cancer Invest. 1995;13(3):263-6. doi: 10.3109/07357909509094459.
3
[A case of unknown primary squamous cell carcinoma in the neck showing a high response with combined chemotherapy including nedaplatin, adriamycin and 5-fluorouracil].1例颈部原发性不明的鳞状细胞癌对含奈达铂、阿霉素和5-氟尿嘧啶的联合化疗显示出高度反应
Gan To Kagaku Ryoho. 2005 Aug;32(8):1149-51.
4
Role of paclitaxel, ifosfamide, and cisplatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.紫杉醇、异环磷酰胺和顺铂在复发或转移性头颈部鳞状细胞癌患者中的作用。
Semin Oncol. 1998 Apr;25(2 Suppl 4):40-4; discussion 45-8.
5
Systemic chemotherapy with cisplatin plus 5-FU (PF) for recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): efficacy and safety of a lower dose of PF (80/800) at a single institution in Japan.顺铂联合5-氟尿嘧啶(PF)用于复发性或转移性头颈部鳞状细胞癌(R/M SCCHN)的全身化疗:日本一家机构采用较低剂量PF(80/800)的疗效和安全性
Jpn J Clin Oncol. 2009 Apr;39(4):225-30. doi: 10.1093/jjco/hyp002. Epub 2009 Feb 10.
6
Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer.一项III期研究,比较顺铂联合氟尿嘧啶与紫杉醇、顺铂和氟尿嘧啶诱导化疗,随后进行同步放化疗用于局部晚期头颈癌的疗效。
J Clin Oncol. 2005 Dec 1;23(34):8636-45. doi: 10.1200/JCO.2004.00.1990. Epub 2005 Nov 7.
7
Analysis of efficacy and toxicity of chemotherapy with cisplatin, 5-fluorouracil, methotrexate and leucovorin (PFML) and radiotherapy in the treatment of locally advanced squamous cell carcinoma of the head and neck.顺铂、5-氟尿嘧啶、甲氨蝶呤和亚叶酸钙联合化疗(PFML)及放疗治疗局部晚期头颈部鳞状细胞癌的疗效和毒性分析
Cancer Chemother Pharmacol. 2007 May;59(6):789-94. doi: 10.1007/s00280-006-0335-1. Epub 2006 Oct 20.
8
Adjuvant docetaxel, cisplatin and 5-fluorouracil (TPF) in locally advanced squamous cell carcinoma of the head and neck.多西他赛、顺铂和5-氟尿嘧啶(TPF)辅助治疗局部晚期头颈部鳞状细胞癌
Anticancer Res. 2006 Jan-Feb;26(1B):559-63.
9
Recent advances in paclitaxel-containing chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck.含紫杉醇化疗在复发性或转移性头颈部鳞状细胞癌治疗中的最新进展。
Semin Oncol. 1997 Dec;24(6 Suppl 19):S19-33-S19-37.
10
Chemotherapy for relapsed head and neck cancer: paclitaxel, cisplatin, and 5-fluorouracil in chemotherapy-naive patients. A dose-finding study.复发性头颈癌的化疗:初治患者使用紫杉醇、顺铂和5-氟尿嘧啶。一项剂量探索性研究。
Semin Oncol. 1997 Dec;24(6 Suppl 19):S19-46-S19-50.